2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation Atorvastatin 20mg - Cerebrovascular Event, Stent Stenosis | Phase 4 | Recruiting | Duan Chuanzhi | 354 | 2024-07-30 | 2026-03-03 |
| SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery Vericiguat, Placebo - Endothelial Dysfunction, Vascular Diseases | Phase 4 | Recruiting | Vanderbilt University Medical Center | 170 | 2023-05-19 | 2026-08-06 |
Brain Death (1) · Brain Diseases (1) · Hemorrhagic Stroke (1) · Intracranial Aneurysm (1) · Ischemic Stroke (1) · Stroke (1) · Vascular Diseases (1)
Cardiovascular Diseases (2) · Central Nervous System Diseases (2) · Nervous System Diseases (2) · Aneurysm (1) · Brain Diseases (1) · Cerebrovascular Disorders (1) · Coma (1) · Consciousness Disorders (1) · Death (1) · Intracranial Arterial Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Unconsciousness (1)
Atorvastatin (1) · vericiguat (1)
Duan Chuanzhi (1) · Vanderbilt University Medical Center (1)
China (1) · United States (1)
Chuanzhi Duan, MD (1) · Marcos Lopez, MD (1)
PMID 10634801, PMID 11498461, PMID 22472556, PMID 24462073, PMID 25355814, PMID 26590269, PMID 29146831, PMID 29327999, PMID 30565953, PMID 31352800, PMID 31504418, PMID 33447904, PMID 34991791, PMID 35292570, PMID 36375835, PMID 36700744, PMID 37324979, PMID 38198155, PMID 38719444
R01HL164909 (1)